Top Markets
#1 ADO Protocol ADO Protocol +11.35%
#2 StonkBroker StonkBroker +3.61%
#3 Ontology Gas Ontology Gas +3.20%
#4 Abey Abey +2.07%
#5 Fake World Assets Fake World Assets +1.89%
#6 DOVU DOVU +1.84%
#7 AUKI AUKI +1.73%
#8 OPENLOOT OPENLOOT +1.50%
#9 TENDIES TENDIES +1.40%
#10 Nillion Nillion +1.30%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Rank in Stocks #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Share Price
$48.45
Market Cap
$1.39B
Change (1 day)
1.16%
Change (1 year)
-
Country
US
Trade LB Pharmaceuticals Inc Common Stock (LBRX)

Category

Healthcare
EPS for LB Pharmaceuticals Inc Common Stock (LBRX)
EPS as of 2026 TTM: 0
According to LB Pharmaceuticals Inc Common Stock latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for LB Pharmaceuticals Inc Common Stock from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH